Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea
· Delayed Price · Currency is KRW 29,250
+50 (0.17%)
At close: Aug 14, 2025, 3:30 PM KST
-18.30% (1Y)
| Market Cap | 1.48T |
| Revenue (ttm) | 141.00B |
| Net Income (ttm) | -1.69B |
| Shares Out | 50.74M |
| EPS (ttm) | -33.58 |
| PE Ratio | n/a |
| Forward PE | 132.98 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 425,020 |
| Average Volume | 390,824 |
| Open | 29,600 |
| Previous Close | 29,200 |
| Day's Range | 29,100 - 30,000 |
| 52-Week Range | 24,000 - 52,000 |
| Beta | 0.82 |
| RSI | 60.44 |
| Earnings Date | Aug 14, 2025 |